Home Healthcare IT Europe Neurodegenerative Disease Market Size, Share & Trends | Industry Report, 2033

Europe Neurodegenerative Disease Market Size & Outlook, 2025-2033

Europe Neurodegenerative Disease Market Size, Share & Trends Analysis Report By Indication Type (Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Huntington Disease, Other Indication Types), By Drug Type (N-methyl-D-aspartate Receptor antagonists, Cholinesterase Inhibitors, Dopamine Agonists, Immunomodulatory Drugs, Other Drug Types) and By Country(U.K., Germany, France, Spain, Italy, Russia, Nordic, Benelux, Rest of Europ) Forecasts, 2025-2033

Report Code: SRHI3166DR
Last Updated : Nov, 2022
Pages : 80
Author : Debashree Bora
Format : PDF, Excel

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. Europe
  2. ESG Trends
    1. Introduction
    2. By Indication Type
      1. Introduction
        1. Indication Type By Value
      2. Parkinson's Disease
        1. By Value
      3. Alzheimer's Disease
        1. By Value
      4. Multiple Sclerosis
        1. By Value
      5. Huntington Disease
        1. By Value
      6. Amyotrophic Lateral Sclerosis
        1. By Value
      7. Spinal Muscular Atrophy (SMA) 
        1. By Value
      8. Other Indication Types
        1. By Value
    3. By Drug Type
      1. Introduction
        1. Drug Type By Value
      2. N-methyl-D-aspartate Receptor antagonists
        1. By Value
      3. Cholinesterase Inhibitors
        1. By Value
      4. Dopamine Agonists
        1. By Value
      5. Immunomodulatory Drugs
        1. By Value
      6. Acetylcholinesterase (AChE) Inhibitors
        1. By Value
      7. Antagonist, Monoamine Oxidase B (MAO-B) Inhibitor
        1. By Value
      8. Catechol-O-Methyltransferase (COMT) Inhibitor
        1. By Value
      9. SSRIs
        1. By Value
      10. Other Drug Types
        1. By Value
    4. U.K.
      1. By Indication Type
        1. Introduction
          1. Indication Type By Value
        2. Parkinson's Disease
          1. By Value
        3. Alzheimer's Disease
          1. By Value
        4. Multiple Sclerosis
          1. By Value
        5. Huntington Disease
          1. By Value
        6. Amyotrophic Lateral Sclerosis
          1. By Value
        7. Spinal Muscular Atrophy (SMA) 
          1. By Value
        8. Other Indication Types
          1. By Value
      2. By Drug Type
        1. Introduction
          1. Drug Type By Value
        2. N-methyl-D-aspartate Receptor antagonists
          1. By Value
        3. Cholinesterase Inhibitors
          1. By Value
        4. Dopamine Agonists
          1. By Value
        5. Immunomodulatory Drugs
          1. By Value
        6. Acetylcholinesterase (AChE) Inhibitors
          1. By Value
        7. Antagonist, Monoamine Oxidase B (MAO-B) Inhibitor
          1. By Value
        8. Catechol-O-Methyltransferase (COMT) Inhibitor
          1. By Value
        9. SSRIs
          1. By Value
        10. Other Drug Types
          1. By Value
    5. Germany
    6. France
    7. Spain
    8. Italy
    9. Russia
    10. Nordic
    11. Benelux
    12. Rest of Europ
    1. Europe Neurodegenerative Disease Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Boehringer Ingelheim International GmbH
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Hoffmann-La Roche AG
    3. UCB SA
    4. Novartis International AG
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Available for purchase with detailed segment data, forecasts, and regional insights.

Get This Report

Download Free Sample

Note: Please ensure you provide an active email address as we will be sending sample details via email.
The button will be active once the above form is filled

Our Clients:

LG Electronics
AMCAD Engineering
KOBE STEEL LTD.
Hindustan National Glass & Industries Limited
Voith Group
International Paper
Hansol Paper
Whirlpool Corporation
Sony
Samsung Electronics
Qualcomm
Google
Fiserv
Veto-Pharma
Nippon Becton Dickinson
Merck
Argon Medical Devices
Abbott
Ajinomoto
Denon
Doosan
Meiji Seika Kaisha Ltd
LG Chemicals
LCY chemical group
Bayer
Airrane
BASF
Toyota Industries
Nissan Motors
Neenah
Mitsubishi
Hyundai Motor Company

We are featured on :

Address:
Office 515 A, Amanora Chambers,
Amanora Park Town, Hadapsar,
Pune 411028, Maharashtra, India.
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
DMCA.com Protection Status
Secure Payments:
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.